Jiayan Ni

727 total citations
26 papers, 537 citations indexed

About

Jiayan Ni is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Jiayan Ni has authored 26 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 13 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Jiayan Ni's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Liver Disease Diagnosis and Treatment (8 papers). Jiayan Ni is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Liver Disease Diagnosis and Treatment (8 papers). Jiayan Ni collaborates with scholars based in China and United States. Jiayan Ni's co-authors include Hongliang Sun, Linfeng Xu, Jianghong Luo, Jingxing Zhou, Xiongying Jiang, Shanshan Liu, Chen Dong, Wei Cui, Jun Zhou and Binhui Xie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and World Journal of Gastroenterology.

In The Last Decade

Jiayan Ni

25 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiayan Ni China 12 383 190 140 104 77 26 537
Yajin Chen China 11 176 0.5× 52 0.3× 127 0.9× 107 1.0× 73 0.9× 22 433
Yi‐Te Lee United States 12 262 0.7× 193 1.0× 72 0.5× 82 0.8× 35 0.5× 26 531
Zhongzhen Guan China 8 191 0.5× 76 0.4× 73 0.5× 133 1.3× 89 1.2× 26 600
Jianmin Ding China 11 298 0.8× 199 1.0× 99 0.7× 55 0.5× 23 0.3× 36 464
Keisuke Hamamura Japan 13 615 1.6× 390 2.1× 202 1.4× 111 1.1× 33 0.4× 25 767
Sirui Fu China 14 231 0.6× 100 0.5× 78 0.6× 77 0.7× 45 0.6× 29 530
Zilin Huang China 13 175 0.5× 64 0.3× 145 1.0× 169 1.6× 60 0.8× 33 524
Alessandra R. Garcia United States 4 356 0.9× 95 0.5× 102 0.7× 97 0.9× 46 0.6× 4 458
Xin‐Fei Xu China 11 449 1.2× 248 1.3× 152 1.1× 112 1.1× 53 0.7× 23 705
Olivier Sutter France 15 620 1.6× 380 2.0× 180 1.3× 126 1.2× 73 0.9× 39 878

Countries citing papers authored by Jiayan Ni

Since Specialization
Citations

This map shows the geographic impact of Jiayan Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayan Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayan Ni more than expected).

Fields of papers citing papers by Jiayan Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayan Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayan Ni. The network helps show where Jiayan Ni may publish in the future.

Co-authorship network of co-authors of Jiayan Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayan Ni. A scholar is included among the top collaborators of Jiayan Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayan Ni. Jiayan Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Han, Xue, Jiayan Ni, Yingying Xu, et al.. (2021). Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study. Abdominal Radiology. 46(8). 3758–3771. 7 indexed citations
4.
Huang, Zhimei, Zhixing Guo, Jiayan Ni, et al.. (2021). Four types of tumor progression after microwave ablation of single hepatocellular carcinoma of ≤5 cm: incidence, risk factors and clinical significance. International Journal of Hyperthermia. 38(1). 1164–1173. 11 indexed citations
5.
6.
Wang, Weidong, et al.. (2020). Effectiveness and safety of irreversible electroporation for recurrent hepatocellular carcinoma ineligible for thermal ablation after surgery. SHILAP Revista de lepidopterología. 3(3). 151–155. 5 indexed citations
7.
Wang, Yu, Binhui Xie, Weihao Lin, et al.. (2019). Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2. Oncogene. 38(25). 4948–4961. 54 indexed citations
8.
9.
Wang, Weidong, Lihua Zhang, Jiayan Ni, et al.. (2018). Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis. Korean Journal of Radiology. 19(4). 613–613. 14 indexed citations
10.
Ni, Jiayan, Jian Kong, Hongliang Sun, et al.. (2017). Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas. Academic Radiology. 25(4). 423–429. 10 indexed citations
11.
Ni, Jiayan, Hongliang Sun, Jianghong Luo, et al.. (2017). Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety. Journal of Cancer Research and Clinical Oncology. 144(1). 157–163. 13 indexed citations
12.
Sun, Hongliang, et al.. (2017). The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT. OncoTargets and Therapy. Volume 10. 3835–3842. 7 indexed citations
13.
Li, Huiqing, Xiongying Jiang, Dong Chen, et al.. (2016). Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study. European Radiology. 26(10). 3500–3509. 3 indexed citations
14.
Ni, Jiayan, et al.. (2016). Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model. Journal of Cancer Research and Clinical Oncology. 143(2). 199–207. 9 indexed citations
15.
Ni, Jiayan. (2014). Conventional transarterial chemoembolizationvsmicrosphere embolization in hepatocellular carcinoma: A meta-analysis. World Journal of Gastroenterology. 20(45). 17206–17206. 26 indexed citations
16.
Sun, Hongliang, Jianghong Luo, Jiayan Ni, et al.. (2014). Interventional digital subtraction angiography for small bowel gastrointestinal stromal tumors with bleeding. World Journal of Gastroenterology. 20(47). 17955–17961. 15 indexed citations
17.
Ni, Jiayan. (2014). Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. World Journal of Gastroenterology. 20(46). 17483–17483. 32 indexed citations
18.
Ni, Jiayan, et al.. (2013). Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients. Journal of Cancer Research and Clinical Oncology. 139(12). 2021–2033. 33 indexed citations
19.
Ni, Jiayan. (2013). Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World Journal of Gastroenterology. 19(24). 3872–3872. 132 indexed citations
20.
Ni, Jiayan, et al.. (2013). Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology. 139(4). 653–659. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yajin Chen Breakdown of academic impact, for papers by Yi‐Te Lee Breakdown of academic impact, for papers by Zhongzhen Guan Breakdown of academic impact, for papers by Jianmin Ding Breakdown of academic impact, for papers by Keisuke Hamamura Breakdown of academic impact, for papers by Sirui Fu Breakdown of academic impact, for papers by Zilin Huang Breakdown of academic impact, for papers by Alessandra R. Garcia Breakdown of academic impact, for papers by Xin‐Fei Xu Breakdown of academic impact, for papers by Olivier Sutter
Rankless by CCL
2026